Ventricular Assist Devices Market Size, Share, 2034

Download Free Sample

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Ventricular Assist Devices Market Size Analysis

Global Ventricular Assist Devices Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Left Ventricular Assist Device (LVAD)
    1. By Value
  3. Right Ventricular Assist Device (RVAD)
    1. By Value
  4. Biventricular Assist Device (BIVAD)
    1. By Value
  5. Total Artificial Heart (TAH)
    1. By Value
2. By Design
  1. Introduction
    1. Design By Value
  2. Implantable VAD
    1. By Value
  3. Transcutaneous / External VAD
    1. By Value
  4. Percutaneous Micro-axial VAD
    1. By Value
3. By Flow Type
  1. Introduction
    1. Flow Type By Value
  2. Pulsatile Flow
    1. By Value
  3. Continuous Flow
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplant (BTT)
    1. By Value
  3. Destination Therapy (DT)
    1. By Value
  4. Bridge-to-Recovery (BTR)
    1. By Value
  5. Bridge-to-Decision
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Left Ventricular Assist Device (LVAD)
    1. By Value
  3. Right Ventricular Assist Device (RVAD)
    1. By Value
  4. Biventricular Assist Device (BIVAD)
    1. By Value
  5. Total Artificial Heart (TAH)
    1. By Value
2. By Design
  1. Introduction
    1. Design By Value
  2. Implantable VAD
    1. By Value
  3. Transcutaneous / External VAD
    1. By Value
  4. Percutaneous Micro-axial VAD
    1. By Value
3. By Flow Type
  1. Introduction
    1. Flow Type By Value
  2. Pulsatile Flow
    1. By Value
  3. Continuous Flow
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplant (BTT)
    1. By Value
  3. Destination Therapy (DT)
    1. By Value
  4. Bridge-to-Recovery (BTR)
    1. By Value
  5. Bridge-to-Decision
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Left Ventricular Assist Device (LVAD)
    1. By Value
  3. Right Ventricular Assist Device (RVAD)
    1. By Value
  4. Biventricular Assist Device (BIVAD)
    1. By Value
  5. Total Artificial Heart (TAH)
    1. By Value
2. By Design
  1. Introduction
    1. Design By Value
  2. Implantable VAD
    1. By Value
  3. Transcutaneous / External VAD
    1. By Value
  4. Percutaneous Micro-axial VAD
    1. By Value
3. By Flow Type
  1. Introduction
    1. Flow Type By Value
  2. Pulsatile Flow
    1. By Value
  3. Continuous Flow
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplant (BTT)
    1. By Value
  3. Destination Therapy (DT)
    1. By Value
  4. Bridge-to-Recovery (BTR)
    1. By Value
  5. Bridge-to-Decision
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Left Ventricular Assist Device (LVAD)
    1. By Value
  3. Right Ventricular Assist Device (RVAD)
    1. By Value
  4. Biventricular Assist Device (BIVAD)
    1. By Value
  5. Total Artificial Heart (TAH)
    1. By Value
2. By Design
  1. Introduction
    1. Design By Value
  2. Implantable VAD
    1. By Value
  3. Transcutaneous / External VAD
    1. By Value
  4. Percutaneous Micro-axial VAD
    1. By Value
3. By Flow Type
  1. Introduction
    1. Flow Type By Value
  2. Pulsatile Flow
    1. By Value
  3. Continuous Flow
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplant (BTT)
    1. By Value
  3. Destination Therapy (DT)
    1. By Value
  4. Bridge-to-Recovery (BTR)
    1. By Value
  5. Bridge-to-Decision
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Left Ventricular Assist Device (LVAD)
  1. By Value
3. Right Ventricular Assist Device (RVAD)
  1. By Value
4. Biventricular Assist Device (BIVAD)
  1. By Value
5. Total Artificial Heart (TAH)
  1. By Value
By Design
1. Introduction
  1. Design By Value
2. Implantable VAD
  1. By Value
3. Transcutaneous / External VAD
  1. By Value
4. Percutaneous Micro-axial VAD
  1. By Value
By Flow Type
1. Introduction
  1. Flow Type By Value
2. Pulsatile Flow
  1. By Value
3. Continuous Flow
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Bridge-to-Transplant (BTT)
  1. By Value
3. Destination Therapy (DT)
  1. By Value
4. Bridge-to-Recovery (BTR)
  1. By Value
5. Bridge-to-Decision
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Left Ventricular Assist Device (LVAD)
    1. By Value
  3. Right Ventricular Assist Device (RVAD)
    1. By Value
  4. Biventricular Assist Device (BIVAD)
    1. By Value
  5. Total Artificial Heart (TAH)
    1. By Value
2. By Design
  1. Introduction
    1. Design By Value
  2. Implantable VAD
    1. By Value
  3. Transcutaneous / External VAD
    1. By Value
  4. Percutaneous Micro-axial VAD
    1. By Value
3. By Flow Type
  1. Introduction
    1. Flow Type By Value
  2. Pulsatile Flow
    1. By Value
  3. Continuous Flow
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Bridge-to-Transplant (BTT)
    1. By Value
  3. Destination Therapy (DT)
    1. By Value
  4. Bridge-to-Recovery (BTR)
    1. By Value
  5. Bridge-to-Decision
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Ventricular Assist Devices Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott Laboratories (US)
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Abiomed, Inc. (US)
Berlin Heart GmbH (Germany)
Jarvik Heart, Inc. (US)
Medtronic plc (Ireland)
Terumo Corporation (Japan)
Getinge AB (Sweden)
Teleflex Incorporated (US)
SynCardia Systems, LLC (US)
CARMAT SA (France)
CorWave SA (France)
BiVACOR Inc. (US)
Evaheart, Inc. (Japan)
Leviticus Cardio Ltd. (Israel)
Procyrion, Inc. (US)
Calon Cardio-Technology Ltd. (UK)
NovaPump GmbH (Germany)

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Jay Mehta

Research Analyst